Decrease in sensitivity of D-dimer for acute venous thromboembolism after starting anticoagulant therapy

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 3, 2002, Pages 241-246

  Couturaud, F ^a   Kearon, Clive ^a   Bates, S M ^a   Ginsberg, J S ^a  

^a HENDERSON GENERAL HOSPITAL   (Canada)

Author keywords

Anticoagulant therapy; D dimer; Deep vein thrombosis; Diagnosis; Pulmonary embolism; Venous thromboembolism

Indexed keywords

D DIMER; HEPARIN;

ANTICOAGULANT THERAPY; ARTICLE; CALCULATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; DRUG EFFECT; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADULT; ANTICOAGULANTS; BIOLOGICAL MARKERS; FALSE NEGATIVE REACTIONS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEPARIN; HUMANS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; SENSITIVITY AND SPECIFICITY; TIME FACTORS; VENOUS THROMBOSIS;

EID: 0036526563     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200204000-00010     Document Type: Article

References (36)

1. Monoclonal antibodies to cross-linked fibrin degradation product (XL-FDP). I. Characterization and preliminary evaluation in plasma
2. Plasma measurement of D-dimer as diagnosis aid in suspected venous thromboembolism: An overview
3. Laboratory diagnosis of venous thromboembolism
4. Quantitative plasma D-dimer levels among patients undergoing pulmonary angiography for suspected pulmonary embolism
5. D-dimers in the diagnosis of pulmonary embolism
6. Application of a novel and rapid whole blood assay for D-dimer in patients with clinically suspected pulmonary embolism
7. Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism
8. Evaluation of a new rapid quantitative D-dimer assay in patients with critically suspected deep vein thrombosis
9. Diagnosis of pulmonary embolism by a decision analysis-based strategy including clinical probability, D-dimer levels, and ultrasonography: A management study
10. The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis
11. D-Dimer testing as an adjunct to ultrasonography in patients with clinically suspected deep vein thrombosis: Prospective cohort study
12. Non-invasive diagnosis of venous thromboembolism
13. Changes in plasma fibrin degradation products as a marker of thrombus evolution in patients with deep vein thrombosis
14. Fibrinolytic and thrombolytic parameters in patients with deep vein thrombosis treated with low molecular weight and standard heparin
15. Therapeutic application of subcutaneous low-molecular-weight heparin in acute venous thrombosis
16. D-dimer and TAT measurement in patients with deep venous thrombosis: Utility in diagnosis and judgement of anticoagulant treatment effectiveness
17. Prothrombin fragment 1 + 2, thrombin-antithrombin III complexes and D-dimers in acute deep vein thrombosis: Effects of heparin treatment
18. Fibrin degradation product D-dimer in the diagnosis of pulmonary embolism
19. Influence of heparin treatment on biochemical markers of an activation of the coagulation system
20. D-dimer and thrombin-antithrombin III complexes in patients with clinically suspected pulmonary embolism
21. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-dimer levels in patients affected by proximal deep vein thrombosis
22. Markers of hemostatic system activation in acute deep venous thrombosis-evolution during the first days of heparin treatment
23. Parameters of haemostasis during acute venous thrombosis
24. Markers of coagulation activation for evaluation of the antithrombotic efficacy of heparin: A prospective study in acute deep venous thrombosis
25. Laboratory assays and duplex scanning outcomes after symptomatic deep vein thrombosis: Preliminary results
26. D-Dimer determination to assess regression of deep venous thrombosis
27. Effects of heparin therapy on fibrinolysis in patients with pulmonary embolism
28. Monitoring of patients with deep-vein thrombosis during and after anticoagulation with D-dimer
29. Hemostatic activation under anticoagulant treatment: A comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis
30. Noninvasive diagnosis of deep vein thrombosis
31. The diagnosis of pulmonary embolism
32. A latex D-dimer reliably excludes venous thromboembolism
33. Exclusion of deep venous thrombosis with D-dimer testing. Comparison of 13 D-dimer methods in 99 outpatients suspected of deep venous thrombosis using venography as reference standard
34. The organization to assess strategies for ischemic syndromes (OASIS) pilot study: Evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation
35. The activation of platelet function, coagulation, and fibrinolysis during radiofrequency catheter ablation in heparinized patients
36. Dose response of intravenous heparin on markers of thrombosis during primary total hip replacement